Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,030) with videos related to
Page
of 103
Sort By:
Scientific Reports
|
June 5, 2024
Cognitive profile, neuroimaging and fluid biomarkers in post-acute COVID-19 syndrome
Núria Guillén, Agnès Pérez-Millan, Neus Falgàs, et al.
Human Gene Therapy. Clinical Development
|
June 6, 2018
Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model
Rachael S Watson Levings, Ted A Broome, Andrew D Smith, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 7, 2007
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs
Robert J Young, Alan D Borthwick, David Brown, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 20, 2006
Structure- and property-based design of factor Xa inhibitors: pyrrolidin-2-ones with acyclic alanyl amides as P4 motifs
Robert J Young, Matthew Campbell, Alan D Borthwick, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 9, 1999
Thrombin inhibitors based on [5,5] trans-fused indane lactams
M Pass, S Abu-Rabie, A Baxter, et al.
Human Gene Therapy. Clinical Development
|
June 6, 2018
Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine Model
Rachael S Watson Levings, Andrew D Smith, Ted A Broome, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2011
The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs
Nigel S Watson, Carl Adams, David Belton, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 7, 2007
Structure and property based design of factor Xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs
Robert J Young, Alan D Borthwick, David Brown, et al.
Green Chemistry : an International Journal and Green Chemistry Resource : GC
|
August 12, 2014
Designing Endocrine Disruption Out of the Next Generation of Chemicals
T T Schug, R Abagyan, B Blumberg, et al.
ESMO Open
|
March 5, 2025
Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARC
C Cuvelier, M Brahmi, I Sobhani, et al.
Page
of 103
Search research articles
Search
Showing results (991-1000 of 1,030) with videos related to
Sort By:
Page
of 103
Scientific Reports
|
June 5, 2024
Cognitive profile, neuroimaging and fluid biomarkers in post-acute COVID-19 syndrome
Núria Guillén, Agnès Pérez-Millan, Neus Falgàs, et al.
Human Gene Therapy. Clinical Development
|
June 6, 2018
Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model
Rachael S Watson Levings, Ted A Broome, Andrew D Smith, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 7, 2007
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs
Robert J Young, Alan D Borthwick, David Brown, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 20, 2006
Structure- and property-based design of factor Xa inhibitors: pyrrolidin-2-ones with acyclic alanyl amides as P4 motifs
Robert J Young, Matthew Campbell, Alan D Borthwick, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 9, 1999
Thrombin inhibitors based on [5,5] trans-fused indane lactams
M Pass, S Abu-Rabie, A Baxter, et al.
Human Gene Therapy. Clinical Development
|
June 6, 2018
Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine Model
Rachael S Watson Levings, Andrew D Smith, Ted A Broome, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2011
The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs
Nigel S Watson, Carl Adams, David Belton, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 7, 2007
Structure and property based design of factor Xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs
Robert J Young, Alan D Borthwick, David Brown, et al.
Green Chemistry : an International Journal and Green Chemistry Resource : GC
|
August 12, 2014
Designing Endocrine Disruption Out of the Next Generation of Chemicals
T T Schug, R Abagyan, B Blumberg, et al.
ESMO Open
|
March 5, 2025
Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARC
C Cuvelier, M Brahmi, I Sobhani, et al.
Page
of 103